Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Beta Bionics Q3 EPS $(0.33) Beats $(0.44) Estimate, Sales $27.253M Beat $23.972M Estimate

Author: Benzinga Newsdesk | October 28, 2025 03:02pm
Beta Bionics (NASDAQ:BBNX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.44) by 24.31 percent. This is a 77.4 percent increase over losses of $(1.46) per share from the same period last year. The company reported quarterly sales of $27.253 million which beat the analyst consensus estimate of $23.972 million by 13.69 percent. This is a 63.14 percent increase over sales of $16.705 million the same period last year.

Posted In: BBNX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist